Product Information
KURVELO-28 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1125 per EA under NDC 68180084473. Its NADAC has been published 316 times since Jun 10, 2020.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180084473
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091408On Market Since
2/7/2021
Price Statistics
The NADAC for KURVELO-28 TABLET has been published 316 times since Jun 10, 2020, and over the history we have for it it has declined 60.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1125 per EA |
|---|---|
| All-time high | $0.2857 (Jun 10, 2020) |
| All-time low | $0.0800 (Nov 20, 2024) |
| 52-week high | $0.1210 |
| 52-week low | $0.1101 |
| Median price | $0.1556 |
| Average price | $0.1603 |
| Largest weekly change | +72.0% (Aug 21, 2024) |
| Weeks tracked | 316 |
| Tracking since | Jun 10, 2020 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of KURVELO-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KURVELO-28 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1125 per EA (NDC 68180084473), effective Jun 24, 2026.
How has the price of KURVELO-28 TABLET changed over time?
Over the history we have for it, the NADAC for KURVELO-28 TABLET has declined 60.6%. It has been tracked across 316 weekly CMS publications since Jun 10, 2020.
What are the highest and lowest recorded NADAC prices for KURVELO-28 TABLET?
Since Jun 10, 2020, the NADAC for KURVELO-28 TABLET has ranged from a low of $0.0800 (Nov 20, 2024) to a high of $0.2857 (Jun 10, 2020), with a median of $0.1556 per EA.
Are there cheaper alternatives to KURVELO-28 TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as KURVELO-28 TABLET, but none are currently priced below it.
Who manufactures KURVELO-28 TABLET?
KURVELO-28 TABLET (NDC 68180084473) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification